Skip to main content
NCBI home page
The Western Journal of Medicine logoLink to The Western Journal of Medicine
. 1989 Feb;150(2):174–179.

Managing malignant pericardial effusion.

A C Buzaid, H S Garewal, B R Greenberg
PMCID: PMC1026330  PMID: 2471362

Abstract

The involvement of the pericardium by metastatic tumors is not uncommon, particularly in patients with lung cancer, breast cancer, lymphomas, leukemias, and melanomas. There are five therapeutic modalities for the treatment of malignant pericardial effusion, including pericardiocentesis, pericardial sclerosis, systemic chemotherapy, radiotherapy, and surgical treatment. The optimal treatment selection is dependent principally on a patient's life expectancy; responsiveness of the tumor to chemotherapy, irradiation, or both; and whether or not cardiac tamponade is present at diagnosis. The overall prognosis of patients with malignant pericardial effusion is primarily influenced by the extent and histologic features of the underlying cancer. Although this condition is usually incurable, a reasonable period of useful palliation can be obtained in most patients.

Full text

PDF
174

Images in this article

177Image
on p.177

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Acquatella G. C., Roura E. T., Maury A. J., Stern R. O., Acquatella H. High incidence of pericardial effusion in non-Hodgkin's lymphoma: usefulness of echocardiography. Eur J Cancer Clin Oncol. 1982 Nov;18(11):1131–1136. doi: 10.1016/0277-5379(82)90094-3. [DOI] [PubMed] [Google Scholar]
  2. Adenle A. D., Edwards J. E. Clinical and pathologic features of metastatic neoplasms of the pericardium. Chest. 1982 Feb;81(2):166–169. doi: 10.1378/chest.81.2.166. [DOI] [PubMed] [Google Scholar]
  3. Agner R. C., Gallis H. A. Pericarditis: differential diagnostic considerations. Arch Intern Med. 1979 Apr;139(4):407–412. doi: 10.1001/archinte.139.4.407. [DOI] [PubMed] [Google Scholar]
  4. Ahmed M., Slayton R. E. Report on drug-induced pericarditis. Cancer Treat Rep. 1980 Feb-Mar;64(2-3):353–355. [PubMed] [Google Scholar]
  5. Alcan K. E., Zabetakis P. M., Marino N. D., Franzone A. J., Michelis M. F., Bruno M. S. Management of acute cardiac tamponade by subxiphoid pericardiotomy. JAMA. 1982 Feb 26;247(8):1143–1148. [PubMed] [Google Scholar]
  6. Almagro U. A., Caya J. G., Remeniuk E. Cardiac tamponade due to malignant pericardial effusion in breast cancer: a case report. Cancer. 1982 May 1;49(9):1929–1933. doi: 10.1002/1097-0142(19820501)49:9<1929::aid-cncr2820490929>3.0.co;2-q. [DOI] [PubMed] [Google Scholar]
  7. Appelqvist P., Maamies T., Gröhn P. Emergency pericardiotomy as primary diagnostic and therapeutic procedure in malignant pericardial tamponade: report of three cases and review of the literature. J Surg Oncol. 1982 Sep;21(1):18–22. doi: 10.1002/jso.2930210105. [DOI] [PubMed] [Google Scholar]
  8. Aymard J. P., Voiriot P., Witz F., Colomb J. N., Lederlin P., Thibaut G., Guerci O., Herbeuval R. Péricardite inaugurale d'une leucémie aiguë monoblastique. Description d'un cas et revue de la littérature. Ann Med Interne (Paris) 1980;131(5):302–304. [PubMed] [Google Scholar]
  9. Berman K., Fielding L. P., Richi A. A. Diagnosis and treatment of malignant pericardial effusion: the subxiphoid approach. Conn Med. 1984 Nov;48(11):701–702. [PubMed] [Google Scholar]
  10. Buck M., Ingle J. N., Giuliani E. R., Gordon J. R., Therneau T. M. Pericardial effusion in women with breast cancer. Cancer. 1987 Jul 15;60(2):263–269. doi: 10.1002/1097-0142(19870715)60:2<263::aid-cncr2820600225>3.0.co;2-n. [DOI] [PubMed] [Google Scholar]
  11. COHEN G. U., PERRY T. M., EVANS J. M. Neoplastic invasion of the heart and pericardium. Ann Intern Med. 1955 Jun;42(6):1238–1245. doi: 10.7326/0003-4819-42-6-1238. [DOI] [PubMed] [Google Scholar]
  12. Callahan J. A., Seward J. B., Nishimura R. A., Miller F. A., Jr, Reeder G. S., Shub C., Callahan M. J., Schattenberg T. T., Tajik A. J. Two-dimensional echocardiographically guided pericardiocentesis: experience in 117 consecutive patients. Am J Cardiol. 1985 Feb 1;55(4):476–479. doi: 10.1016/0002-9149(85)90397-2. [DOI] [PubMed] [Google Scholar]
  13. Callahan J. A., Seward J. B., Tajik A. J., Holmes D. R., Jr, Smith H. C., Reeder G. S., Miller F. A., Jr Pericardiocentesis assisted by two-dimensional echocardiography. J Thorac Cardiovasc Surg. 1983 Jun;85(6):877–879. [PubMed] [Google Scholar]
  14. Cham W. C., Freiman A. H., Carstens P. H., Chu F. C. Radiation therapy of cardiac and pericardial metastases. Radiology. 1975 Mar;114(3):701–704. doi: 10.1148/114.3.701. [DOI] [PubMed] [Google Scholar]
  15. Chandraratna P. A., Aronow W. S. Detection of pericardial metastases by cross-section echocardiography. Circulation. 1981 Jan;63(1):197–199. doi: 10.1161/01.cir.63.1.197. [DOI] [PubMed] [Google Scholar]
  16. Chen K. T. Extracardiac malignancy presenting with cardiac tamponade. J Surg Oncol. 1983 Jul;23(3):167–168. doi: 10.1002/jso.2930230308. [DOI] [PubMed] [Google Scholar]
  17. Clarke D. P., Cosgrove D. O. Real-time ultrasound scanning in the planning and guidance of pericardiocentesis. Clin Radiol. 1987 Mar;38(2):119–122. doi: 10.1016/s0009-9260(87)80005-3. [DOI] [PubMed] [Google Scholar]
  18. Cohen J. L. Neoplastic pericarditis. Cardiovasc Clin. 1976;7(3):257–269. [PubMed] [Google Scholar]
  19. Davis S., Rambotti P., Grignani F. Intrapericardial tetracycline sclerosis in the treatment of malignant pericardial effusion: an analysis of thirty-three cases. J Clin Oncol. 1984 Jun;2(6):631–636. doi: 10.1200/JCO.1984.2.6.631. [DOI] [PubMed] [Google Scholar]
  20. Davis S., Sharma S. M., Blumberg E. D., Kim C. S. Intrapericardial tetracycline for the management of cardiac tamponade secondary to malignant pericardial effusion. N Engl J Med. 1978 Nov 16;299(20):1113–1114. doi: 10.1056/NEJM197811162992006. [DOI] [PubMed] [Google Scholar]
  21. Flannery E. P., Gregoratos G., Corder M. P. Pericardial effusions in patients with malignant diseases. Arch Intern Med. 1975 Jul;135(7):976–977. [PubMed] [Google Scholar]
  22. Fraser R. S., Viloria J. B., Wang N. S. Cardiac tamponade as a presentation of extracardiac malignancy. Cancer. 1980 Apr 1;45(7):1697–1704. doi: 10.1002/1097-0142(19800401)45:7<1697::aid-cncr2820450730>3.0.co;2-j. [DOI] [PubMed] [Google Scholar]
  23. GOLDMAN B. S., PEARSON F. G. MALIGNANT PERICARDIAL EFFUSION. REVIEW OF HOSPITAL EXPERIENCE AND REPORT OF A CASE SUCCESSFULLY TREATED BY TALC POUDRAGE. Can J Surg. 1965 Apr;8:157–161. [PubMed] [Google Scholar]
  24. GOUDIE R. B. Secondary tumours of the heart and pericardium. Br Heart J. 1955 Apr;17(2):183–188. doi: 10.1136/hrt.17.2.183. [DOI] [PMC free article] [PubMed] [Google Scholar]
  25. Ghosh S. C., Larrieu A. J., Ablaza S. G., Grana V. P. Clinical experience with subxyphoid pericardial decompression. Int Surg. 1985 Jan-Mar;70(1):5–7. [PubMed] [Google Scholar]
  26. Glancy D. L., Roberts W. C. The heart in malignant melanoma. A study of 70 autopsy cases. Am J Cardiol. 1968 Apr;21(4):555–571. doi: 10.1016/0002-9149(68)90289-0. [DOI] [PubMed] [Google Scholar]
  27. Gregory J. R., McMurtrey M. J., Mountain C. F. A surgical approach to the treatment of pericardial effusion in cancer patients. Am J Clin Oncol. 1985 Aug;8(4):319–323. doi: 10.1097/00000421-198508000-00009. [DOI] [PubMed] [Google Scholar]
  28. Grenadier E., Lima C. O., Barron J. V., Allen H. D., Sahn D. J., Valdes-Cruz L. M., Hutter J. J., Goldberg S. J. Two-dimensional echocardiography for evaluation of metastatic cardiac tumors in pediatric patients. Am Heart J. 1984 Jan;107(1):122–126. doi: 10.1016/0002-8703(84)90145-5. [DOI] [PubMed] [Google Scholar]
  29. Guberman B. A., Fowler N. O., Engel P. J., Gueron M., Allen J. M. Cardiac tamponade in medical patients. Circulation. 1981 Sep;64(3):633–640. doi: 10.1161/01.cir.64.3.633. [DOI] [PubMed] [Google Scholar]
  30. HURST J. W., COPPER H. R. Neoplastic disease of the heart. Am Heart J. 1955 Nov;50(5):782–802. doi: 10.1016/0002-8703(55)90186-1. [DOI] [PubMed] [Google Scholar]
  31. Hancock E. W. Pericardial disease--differential diagnosis and management. Hosp Pract (Off Ed) 1983 Apr;18(4):101–112. doi: 10.1080/21548331.1983.11702516. [DOI] [PubMed] [Google Scholar]
  32. Hankins J. R., Satterfield J. R., Aisner J., Wiernik P. H., McLaughlin J. S. Pericardial window for malignant pericardial effusion. Ann Thorac Surg. 1980 Nov;30(5):465–471. doi: 10.1016/s0003-4975(10)61298-2. [DOI] [PubMed] [Google Scholar]
  33. Harrer W. V., Lewis P. L. Metastatic tumors involving the heart and pericardium. Pa Med. 1971 Apr;74(4):57–60. [PubMed] [Google Scholar]
  34. Hausheer F. H., Yarbro J. W. Diagnosis and treatment of malignant pleural effusion. Semin Oncol. 1985 Mar;12(1):54–75. [PubMed] [Google Scholar]
  35. Hill G. J., 2nd, Cohen B. I. Pleural pericardial window for palliation of cardiac tamponade due to cancer. Cancer. 1970 Jul;26(1):81–93. doi: 10.1002/1097-0142(197007)26:1<81::aid-cncr2820260110>3.0.co;2-8. [DOI] [PubMed] [Google Scholar]
  36. Hirsch D. M., Jr, Nydick I. N., Farrow J. H. Malignant pericardial effusion secondary to metastatic breast carcinoma. A case of long-term remission. Cancer. 1966 Sep;19(9):1269–1272. doi: 10.1002/1097-0142(196609)19:9<1269::aid-cncr2820190912>3.0.co;2-l. [DOI] [PubMed] [Google Scholar]
  37. Javier B. V., Yount W. J., Hall T. C., Crosby D. J. The clinical implications of cardiac metastasis from solid tumors. A clinical analysis of 292 cases proved at autopsy. Neoplasma. 1967;14(6):561–574. [PubMed] [Google Scholar]
  38. Johnson M. H., Soulen R. L. Echocardiography of cardiac metastases. AJR Am J Roentgenol. 1983 Oct;141(4):677–681. doi: 10.2214/ajr.141.4.677. [DOI] [PubMed] [Google Scholar]
  39. Kaetz H. W., Selsky L. M. X-ray therapy in the treatment of cardiac tamponade in chronic myelocytic leukemia. Report of a case. Conn Med. 1968 Jul;32(7):523–524. [PubMed] [Google Scholar]
  40. Kagan A. R., Hafermann M., Hamilton M., Pierce R., Morton D., Johnson R. Etiology, diagnosis and management of pericardial effusion after irradiation. Radiol Clin Biol. 1972;41(3):171–182. [PubMed] [Google Scholar]
  41. Kline I. K. Cardiac lymphatic involvement by metastatic tumor. Cancer. 1972 Mar;29(3):799–808. doi: 10.1002/1097-0142(197203)29:3<799::aid-cncr2820290338>3.0.co;2-j. [DOI] [PubMed] [Google Scholar]
  42. Krikorian J. G., Hancock E. W. Pericardiocentesis. Am J Med. 1978 Nov;65(5):808–814. doi: 10.1016/0002-9343(78)90800-8. [DOI] [PubMed] [Google Scholar]
  43. Liedtke A. J., Adams D. F., Weber E. T., Gorlin R. Remission of cardiac lymphoma with supervoltage radiation. Am J Med. 1971 Jun;50(6):816–822. doi: 10.1016/0002-9343(71)90190-2. [DOI] [PubMed] [Google Scholar]
  44. Liepman M. K., Goodlerner S. Surgical management of pericardial tamponade as a presenting manifestation of acute leukemia. J Surg Oncol. 1981;17(2):183–188. doi: 10.1002/jso.2930170214. [DOI] [PubMed] [Google Scholar]
  45. Little A. G., Kremser P. C., Wade J. L., Levett J. M., DeMeester T. R., Skinner D. B. Operation for diagnosis and treatment of pericardial effusions. Surgery. 1984 Oct;96(4):738–744. [PubMed] [Google Scholar]
  46. Lokich J. J. The management of malignant pericardial effusions. JAMA. 1973 Jun 4;224(10):1401–1404. [PubMed] [Google Scholar]
  47. Lund B. Pericardial effusion in advanced ovarian carcinoma. A literature review and report of two cases. Acta Obstet Gynecol Scand. 1985;64(5):443–445. doi: 10.3109/00016348509155164. [DOI] [PubMed] [Google Scholar]
  48. López J. M., Delgado J. L., Tovar E., González A. G. Massive pericardial effusion produced by extracardiac malignant neoplasms. Arch Intern Med. 1983 Sep;143(9):1815–1816. doi: 10.1001/archinte.1983.00350090197038. [DOI] [PubMed] [Google Scholar]
  49. Maher E. R., Buckman R. Intrapericardial installation of bleomycin in malignant pericardial effusion. Am Heart J. 1986 Mar;111(3):613–614. doi: 10.1016/0002-8703(86)90080-3. [DOI] [PubMed] [Google Scholar]
  50. Markiewicz W., Glatstein E., London E. J., Popp R. L. Echocardiographic detection of pericardial effusion and pericardial thickening in malignant lymphoma. Radiology. 1977 Apr;123(1):161–164. doi: 10.1148/123.1.161. [DOI] [PubMed] [Google Scholar]
  51. Martin R. G., Ruckdeschel J. C., Chang P., Byhardt R., Bouchard R. J., Wiernik P. H. Radiation-related pericarditis. Am J Cardiol. 1975 Feb;35(2):216–220. doi: 10.1016/0002-9149(75)90004-1. [DOI] [PubMed] [Google Scholar]
  52. Martini N., Freiman A. H., Watson R. C., Hilaris B. S. Intrapericardial installation of radioactive chromic phosphate in malignant effusion. AJR Am J Roentgenol. 1977 Apr;128(4):639–641. doi: 10.2214/ajr.128.4.639. [DOI] [PubMed] [Google Scholar]
  53. McKenna R. J., Jr, Ali M. K., Ewer M. S., Frazier O. H. Pleural and pericardial effusions in cancer patients. Curr Probl Cancer. 1985 Jun;9(6):1–44. doi: 10.1016/s0147-0272(85)80034-9. [DOI] [PubMed] [Google Scholar]
  54. Mill W. B., Baglan R. J., Kurichety P., Prasad S., Lee J. Y., Moller R. Symptomatic radiation-induced pericarditis in Hodgkin's disease. Int J Radiat Oncol Biol Phys. 1984 Nov;10(11):2061–2065. doi: 10.1016/0360-3016(84)90203-7. [DOI] [PubMed] [Google Scholar]
  55. Miller J. I., Mansour K. A., Hatcher C. R., Jr Pericardiectomy: current indications, concepts, and results in a university center. Ann Thorac Surg. 1982 Jul;34(1):40–45. doi: 10.1016/s0003-4975(10)60850-8. [DOI] [PubMed] [Google Scholar]
  56. Morin J. E., Hollomby D., Gonda A., Long R., Dobell A. R. Management of uremic pericarditis: a report of 11 patients with cardiac tamponade and a review of the literature. Ann Thorac Surg. 1976 Dec;22(6):588–592. doi: 10.1016/s0003-4975(10)64478-5. [DOI] [PubMed] [Google Scholar]
  57. Mufti G. J., Oscier D. G., Hamblin T. J., Nightingale A., Darlow S. Serous effusions in monocytic leukaemias. Br J Haematol. 1984 Nov;58(3):547–552. doi: 10.1111/j.1365-2141.1984.tb04002.x. [DOI] [PubMed] [Google Scholar]
  58. Osuch J. R., Khandekar J. D., Fry W. A. Emergency subxiphoid pericardial decompression for malignant pericardial effusion. Am Surg. 1985 Jun;51(6):298–300. [PubMed] [Google Scholar]
  59. Petersen C. D., Robinson W. A., Kurnick J. E. Involvement of the heart and pericardium in the malignant lymphomas. Am J Med Sci. 1976 Sep-Oct;272(2):161–165. doi: 10.1097/00000441-197609000-00005. [DOI] [PubMed] [Google Scholar]
  60. Piehler J. M., Pluth J. R., Schaff H. V., Danielson G. K., Orszulak T. A., Puga F. J. Surgical management of effusive pericardial disease. Influence of extent of pericardial resection on clinical course. J Thorac Cardiovasc Surg. 1985 Oct;90(4):506–516. [PubMed] [Google Scholar]
  61. Posner M. R., Cohen G. I., Skarin A. T. Pericardial disease in patients with cancer. The differentiation of malignant from idiopathic and radiation-induced pericarditis. Am J Med. 1981 Sep;71(3):407–413. doi: 10.1016/0002-9343(81)90168-6. [DOI] [PubMed] [Google Scholar]
  62. Prager R. L., Wilson C. H., Bender H. W., Jr The subxiphoid approach to pericardial disease. Ann Thorac Surg. 1982 Jul;34(1):6–9. doi: 10.1016/s0003-4975(10)60844-2. [DOI] [PubMed] [Google Scholar]
  63. Press O. W., Livingston R. Management of malignant pericardial effusion and tamponade. JAMA. 1987 Feb 27;257(8):1088–1092. [PubMed] [Google Scholar]
  64. Primrose W. R., Clee M. D., Johnston R. N. Malignant pericardial effusion managed with Vinblastine. Clin Oncol. 1983 Mar;9(1):67–70. [PubMed] [Google Scholar]
  65. ROSENBERG S. A., DIAMOND H. D., JASLOWITZ B., CRAVER L. F. Lymphosarcoma: a review of 1269 cases. Medicine (Baltimore) 1961 Feb;40:31–84. doi: 10.1097/00005792-196102000-00002. [DOI] [PubMed] [Google Scholar]
  66. Reyes C. V., Strinden C., Banerji M. The role of cytology in neoplastic cardiac tamponade. Acta Cytol. 1982 May-Jun;26(3):299–302. [PubMed] [Google Scholar]
  67. Reynolds P. M., Byrne M. J. The treatment of malignant pericardial effusion in carcinoma of the breast. Aust N Z J Med. 1977 Apr;7(2):169–171. doi: 10.1111/j.1445-5994.1977.tb04688.x. [DOI] [PubMed] [Google Scholar]
  68. Roberts W. C., Glancy D. L., DeVita V. T., Jr Heart in malignant lymphoma (Hodgkin's disease, lymphosarcoma, reticulum cell sarcoma and mycosis fungoides). A study of 196 autopsy cases. Am J Cardiol. 1968 Jul;22(1):85–107. doi: 10.1016/0002-9149(68)90250-6. [DOI] [PubMed] [Google Scholar]
  69. Ruckdeschel J. C., Chang P., Martin R. G., Byhardt R. W., O'Connell M. J., Sutherland J. C., Wiernik P. H. Radiation-related pericardial effusions in patients with Hodgkin's disease. Medicine (Baltimore) 1975 May;54(3):245–259. doi: 10.1097/00005792-197505000-00005. [DOI] [PubMed] [Google Scholar]
  70. SUHRLAND L. G., WEISBERGER A. S. INTRACAVITARY 5-FLUOROURACIL IN MALIGNANT EFFUSIONS. Arch Intern Med. 1965 Sep;116:431–433. doi: 10.1001/archinte.1965.03870030111019. [DOI] [PubMed] [Google Scholar]
  71. Shepherd F. A., Ginsberg J. S., Evans W. K., Scott J. G., Oleksiuk F. Tetracycline sclerosis in the management of malignant pericardial effusion. J Clin Oncol. 1985 Dec;3(12):1678–1682. doi: 10.1200/JCO.1985.3.12.1678. [DOI] [PubMed] [Google Scholar]
  72. Shepherd F. A., Morgan C., Evans W. K., Ginsberg J. F., Watt D., Murphy K. Medical management of malignant pericardial effusion by tetracycline sclerosis. Am J Cardiol. 1987 Nov 15;60(14):1161–1166. doi: 10.1016/0002-9149(87)90411-5. [DOI] [PubMed] [Google Scholar]
  73. Smith F. E., Lane M., Hudgins P. T. Conservative management of malignant pericardial effusion. Cancer. 1974 Jan;33(1):47–57. doi: 10.1002/1097-0142(197401)33:1<47::aid-cncr2820330110>3.0.co;2-8. [DOI] [PubMed] [Google Scholar]
  74. Sobol S. M., Thomas H. M., Jr, Evans R. W. Myocardial laceration not demonstrated by continuous electrocardiographic monitoring occurring during pericardiocentesis. N Engl J Med. 1975 Jun 5;292(23):1222–1223. doi: 10.1056/NEJM197506052922306. [DOI] [PubMed] [Google Scholar]
  75. Sulkes A., Weshler Z., Kopolovic Y. Pericardial effusion as first evidence of malignancy in bronchogenic carcinoma. J Surg Oncol. 1982 Jun;20(2):71–74. doi: 10.1002/jso.2930200202. [DOI] [PubMed] [Google Scholar]
  76. THURBER D. L., EDWARDS J. E., ACHOR R. W. Secondary malignant tumors of the pericardium. Circulation. 1962 Aug;26:228–241. doi: 10.1161/01.cir.26.2.228. [DOI] [PubMed] [Google Scholar]
  77. Tatsuta M., Yamamura H., Yamamoto R., Ichii M., Iishi H., Noguchi S. Carcinoembryonic antigens in the pericardial fluid of patients with malignant pericarditis. Oncology. 1984;41(5):328–330. doi: 10.1159/000225848. [DOI] [PubMed] [Google Scholar]
  78. Terry L. N., Jr, Kligerman M. M. Pericardial and myocardial involvement by lymphomas and leukemias. The role of radiotherapy. Cancer. 1970 May;25(5):1003–1008. doi: 10.1002/1097-0142(197005)25:5<1003::aid-cncr2820250503>3.0.co;2-w. [DOI] [PubMed] [Google Scholar]
  79. Tominaga K., Shinkai T., Eguchi K., Saijo N., Sasaki Y., Beppu Y., Nishikawa K. The value of two-dimensional echocardiography in detecting malignant tumors in the heart. Cancer. 1986 Oct 15;58(8):1641–1647. doi: 10.1002/1097-0142(19861015)58:8<1641::aid-cncr2820580811>3.0.co;2-1. [DOI] [PubMed] [Google Scholar]
  80. WEISBERGER A. S., LEVINE B., STORAASLI J. P. Use of nitrogen mustard in treatment of serous effusions of neoplastic origin. J Am Med Assoc. 1955 Dec 31;159(18):1704–1707. doi: 10.1001/jama.1955.02960350004002. [DOI] [PubMed] [Google Scholar]
  81. Wei J. Y., Taylor G. J., Achuff S. C. Recurrent cardiac tamponade and large pericardial effusions: management with an indwelling pericardial catheter. Am J Cardiol. 1978 Aug;42(2):281–282. doi: 10.1016/0002-9149(78)90911-6. [DOI] [PubMed] [Google Scholar]
  82. Wong B., Murphy J., Chang C. J., Hassenein K., Dunn M. The risk of pericardiocentesis. Am J Cardiol. 1979 Nov;44(6):1110–1114. doi: 10.1016/0002-9149(79)90176-0. [DOI] [PubMed] [Google Scholar]
  83. Yazdi H. M., Hajdu S. I., Melamed M. R. Cytopathology of pericardial effusions. Acta Cytol. 1980 Sep-Oct;24(5):401–412. [PubMed] [Google Scholar]
  84. Zipf R. E., Jr, Johnston W. W. The role of cytology in the evaluation of pericardial effusions. Chest. 1972 Nov;62(5):593–596. doi: 10.1378/chest.62.5.593. [DOI] [PubMed] [Google Scholar]

Articles from Western Journal of Medicine are provided here courtesy of BMJ Publishing Group

RESOURCES